GREAT POINT PARTNERS LLC
CIK 1281446 · Holdings on Mar 31, 2024 · First reported May 15, 2024
Top ten holdings
Q1 2024- NGNE7.97%
- NVLS6.97%
- URGN6.13%
- ABVX5.55%
- EOLS5.35%
- PLRX4.30%
- APGE4.14%
- 0080641074.09%
- VRDN3.64%
- ANAB3.43%
Share classes counted separately51.57%
Portfolio value by quarter
What changed this quarter?
Within preview · weight change- NVLSWeight decreased · -5.06 pp12.03% → 6.97%Shares -2.57M (-69.53%)
- CYTKWeight decreased · -4.90 pp7.11% → 2.21%Shares -297.80K (-59.56%)
- NGNEWeight increased · +4.69 pp3.28% → 7.97%Shares +10.06K (+1.01%)
Weight = security value ÷ total reported holdings value. Changes are in percentage points; price moves also affect weights, so they are not trade sizes.
Top 10 holdings 30
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | NGNENEUROGENE INC View history and evidence | $51.12M | 7.97% | 1.00M shares | 3.28% → 7.97%+4.69 pp +10.06K (+1.01%) | Added | ↗▾ |
| 02 | NVLSALPINE IMMUNE SCIENCES INC View history and evidence | $44.73M | 6.97% | 1.13M shares | 12.03% → 6.97%-5.06 pp -2.57M (-69.53%) | Reduced | ↗▾ |
| 03 | URGNUROGEN PHARMA LTD View history and evidence | $39.31M | 6.13% | 2.62M shares | 6.70% → 6.13%-0.57 pp 0 (0.00%) | Unchanged | ↗▾ |
| 04 | ABVXABIVAX SA-ADRSPONSORED ADS View history and evidence | $35.59M | 5.55% | 2.49M shares | 2.83% → 5.55%+2.72 pp +938.48K (+60.55%) | Added | ↗▾ |
| 05 | EOLSEVOLUS INC View history and evidence | $34.30M | 5.35% | 2.45M shares | 3.59% → 5.35%+1.76 pp +450.00K (+22.50%) | Added | ↗▾ |
| 06 | PLRXPLIANT THERAPEUTICS INC View history and evidence | $27.59M | 4.30% | 1.85M shares | 5.63% → 4.30%-1.33 pp +28.68K (+1.57%) | Added | ↗▾ |
| 07 | APGEAPOGEE THERAPEUTICS INC View history and evidence | $26.58M | 4.14% | 400.00K shares | 1.90% → 4.14%+2.24 pp 0 (0.00%) | Unchanged | ↗▾ |
| 08 | 008064107AEROVATE THERAPEUTICS INC View history and evidence | $26.25M | 4.09% | 887.69K shares | 4.00% → 4.09%+0.09 pp -150.00K (-14.46%) | Reduced | ↗▾ |
| 09 | VRDNVIRIDIAN THERAPEUTICS INC View history and evidence | $23.38M | 3.64% | 1.33M shares | Prior unavailable +1.33M | New | ↗▾ |
| 10 | ANABANAPTYSBIO INC View history and evidence | $22.00M | 3.43% | 976.98K shares | 3.57% → 3.43%-0.14 pp 0 (0.00%) | Unchanged | ↗▾ |
Options overlay 0
No options reported this quarter.
Exited positions 9
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| RARE ULTRAGENYX PHARMACEUTICAL IN | Non-derivative | -648,000 | -$30.99M | SEC filing ↗ | SEC filing ↗ |
| RAPT RAPT THERAPEUTICS INC | Non-derivative | -1,099,753 | -$27.33M | SEC filing ↗ | SEC filing ↗ |
| ALKS ALKERMES PLC | Non-derivative | -875,044 | -$24.27M | SEC filing ↗ | SEC filing ↗ |
3 / 9 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 1281446 · Period 2024-03-31
Data loaded 2026-09-23 · First reported 2024-05-15
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 641637881
}Research all 35 reported holdings.
This page includes 30 of 35 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 30 of 35 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"1281446","quarter":"2024Q1","page_size":100}
get_institutional_manager_history
{"cik":"1281446","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.